Skip to main content

Acute Effects of the Human Recombinant Tumor Necrosis Factor (rTNF) on the Cerebral Vasculature of the Rat in Both Normal Brain and an Experimental Glioma Model

  • Chapter
Biological Aspects of Brain Tumors

Abstract

Since its isolation by Carswell et al. in 1975 [1] as the agent responsible for hemorrhagic necrosis of sarcoma, the tumor necrosis factor (TNF-α) has been implicated in a variety of physiological activities. Studies in animal models and humans have shown that at least one of the cytokine’s antitumor actions is mediated through these inflammatory mechanisms, leading to hemorrhagic necrosis of tumors [2]. The successful cloning of TNF-α DNA in 1985 [3] and production of recombinant TNF-α (rTNF-α) was followed by an increase in research to more clearly define the specific actions of the cytokine. In vitro, rTNF-α was shown to increase neutrophil adherence to endothelial cells, induce an adhesion-dependent migration of neutrophils through endothelial monolayers, enhance endothelial susceptibility to neutrophil-mediated killing, and stimulate neutrophil respiratory burst and degranulation [4,5]. The mechanism of TNF-α’s action, therefore, is thought to be through neutrophils which, when stimulated by TNF-α, release H2O2, resulting in the production of tissue-damaging oxygen radicals [6]. TNF-α may also be directly cytotoxic for tumor cells through stimulation of the production of oxygen radicals in the cells themselves [7].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Nat Acad Sci USA 72: 3666–3670

    Article  PubMed  CAS  Google Scholar 

  2. Asher A, Mule JJ, Reichert CM, Shiloni E, Rosenberg SA (1987) Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 138: 963–974

    PubMed  CAS  Google Scholar 

  3. Shirai T, Tamaguchi H, Ito H, Todd CW, Wallance B (1985) Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature 313: 803–806

    Article  PubMed  CAS  Google Scholar 

  4. Moser R, Schleiffenbaum B, Groscurth P, Fehr J (1989) Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 83: 444–455

    Article  PubMed  CAS  Google Scholar 

  5. Varani J, Bendelow MJ, Sealey DE, Kunkel SL, Gannon DE, Ryan US, Ward PA (1988) Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil-mediated killing. Lab Invest 59: 292–295

    PubMed  CAS  Google Scholar 

  6. Shau H (1988) Characteristics and mechanism of neutrophil-mediated cytostasis induced by tumor necrosis factor. J Immunol 141: 234–240

    PubMed  CAS  Google Scholar 

  7. Neal ML, Fiera RA, Matthews N (1988) Involvement of phospholipase A2 activation in tumor cell killing by tumor necrosis factor. Immunology 64: 81–85

    Google Scholar 

  8. Kimura K, Taguchi T, Urushizaki I, Ohno R, Abe O, Furue H, Hattori T, Ichihashi I, Inoguchi K, Majima H, Niitani H, Ota K, Saito T, Suga S (1987) The A-TNF Cooperative Study Group: Phase I study of recombinant human tumor necrosis factor. Cancer Chemother Pharmacol 20: 223–229

    Article  PubMed  CAS  Google Scholar 

  9. Flectcher WH, Shiu WW, Ishada TA, Haviland DL, Ware CF (1987) Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells. J Immunol 139: 956–962

    Google Scholar 

  10. Selmaji KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Kido, G., Nakamura, S., Tsubokawa, T., Merchant, R.E., Young, H.F. (1991). Acute Effects of the Human Recombinant Tumor Necrosis Factor (rTNF) on the Cerebral Vasculature of the Rat in Both Normal Brain and an Experimental Glioma Model. In: Tabuchi, K. (eds) Biological Aspects of Brain Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68150-2_28

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68150-2_28

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68152-6

  • Online ISBN: 978-4-431-68150-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics